Tower One Construction Update for the Month of April 2021
VANCOUVER, British Columbia, May 14, 2021 (GLOBE NEWSWIRE) -- TOWER ONE WIRELESS CORP. (CSE: TO) (OTCQB: TOWTF) (Frankfurt: 1P3N) (“Tower...
Month: May 2021
Quantity of shares in Nexstim Plc after completion of the first phase in reducing the quantity of shares
Company announcement, Helsinki, 14 May 2021 at 9 PM (EEST) Quantity of shares in Nexstim Plc after completion of the...
Qualigen Therapeutics, Inc. Reports First Quarter 2021 Financial Results and Provides Corporate Update
Conference call scheduled for May 18, 2021 at 4:10 p.m. EDT. Revenues Increased 30 Percent to $1.9 Million Compared to...
IntelGenx Announces Initial Closing of atai Investment
SAINT LAURENT, Quebec, May 14, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films,...
A Vision for Canada’s Children, Youth and Families Released Today
OTTAWA, May 14, 2021 (GLOBE NEWSWIRE) -- To mark International Day of Families, an unprecedented, collaborative vision for Canada’s future...
NeuBase Therapeutics to Participate in Upcoming Investor Conferences in May 2021
RBC Capital Markets Virtual Global Healthcare Conference Fireside Chat at 11:30 a.m. ET on May 19 Oppenheimer Rare & Orphan Disease...
Somnology Wins “Best Sleep Monitoring Solution” Award in 2021 MedTech Breakthrough Awards Program
Annual Awards Program Recognizes Outstanding Health & Medical Technology Products and Companies REDWOOD CITY, Calif.--(BUSINESS WIRE)--Somnology, a premier sleep monitoring...
KLAS Research Awards High Ratings to uPerform, the Leading Healthcare Digital Learning Platform
ANCILE partners with KLAS Research for Disrupting Traditional Software Training First Look Report ELKRIDGE, Md.--(BUSINESS WIRE)--#EHR--ANCILE Solutions, the company behind...
Jaguar Health Announces Adjournment of Annual Meeting of Stockholders Until Friday, June 11, 2021 and Encourages All Shareholders to Vote
Based on a preliminary review of votes cast, over 80% have voted in favor of Proposals 2, 3, 4 &...
Biotricity to Present its Disruptive Medical Technologies at the Benzinga Global Small Cap Conference on May 14
Presentation to focus on flagship Bioflux® product for the multi-billion cardiac monitoring and diagnostic market REDWOOD CITY, CA / ACCESSWIRE...
Havn Life CEO Tim Moore to Appear at Upcoming Q2 Investor SummitHavn Life CEO Tim Moore to Appear at Upcoming Q2 Investor Summit
Havn Life will join 80+ other small cap and micro-cap companies at leading event for investors VANCOUVER, BC / ACCESSWIRE...
Praxis Precision Medicines to Present at Upcoming Investor Conferences
CAMBRIDGE, Mass., May 14, 2021 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic...
GBS Inc. Reports First Quarter 2021 Financial Results and Recent Business Highlights
- Anticipate Emergency Use Submission for SARS-CoV-2Antibody Biosensor Test in the Second Half of 2021- - $14 Million in Cash,...
Fluidigm to Present at Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., May 14, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a...
Auris Medical Reaches Midpoint for Enrollment in Part B of AM-125 Phase 2 TRAVERS Trial in Acute Peripheral Vertigo
Hamilton, Bermuda, May 14, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that...
Misonix Appoints Patrick J. Beyer to Board of Directors
Leading Medical Tech Executive Brings Extensive Industry Knowledge, Strategic Leadership and Financial Expertise to BoardFARMINGDALE, N.Y., May 14, 2021 (GLOBE NEWSWIRE)...
Evoke Pharma Appoints Vickie Reed to Board of Directors
SOLANA BEACH, Calif., May 14, 2021 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on...
Ultragenyx Announces Positive Multi-Year Durability Data from Ongoing Phase 1/2 Gene Therapy Studies and Data on HeLa 3.0 Manufacturing Platform at American Society of Gene & Cell Therapy 2021 Annual Meeting
Durable and Clinically Meaningful Responses Maintained at More than 2.5 and 3 Years Post-Treatment in Phase 1/2 Studies of DTX401...
SCYNEXIS Secures Term Loan Facility for up to $60 Million with Hercules Capital and Silicon Valley Bank
Together with SCYNEXIS’ $93M cash balance at 12/31/20, the non-dilutive capital injections from this term loan, the recent licensing payments...
RSA Appoints Ellen Purdy as Chief Financial Officer of Fraud & Risk Intelligence Business
Accomplished Executive with over 20 Years of Financial, Operations, and M&A Leadership Experience to Support Rapid Growth and Scale BEDFORD,...